Compile Data Set for Download or QSAR
Report error Found 176 Enz. Inhib. hit(s) with all data for entry = 9269
TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454352(US10717734, Compound 28)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454353(US10717734, Compound 29)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454351(US10717734, Compound 27)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454352(US10717734, Compound 28)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454350(US10717734, Compound 26)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454351(US10717734, Compound 27)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454349(US10717734, Compound 25)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454350(US10717734, Compound 26)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454348(US10717734, Compound 24)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454349(US10717734, Compound 25)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454346(US10717734, Compound 22 | US10717734, Compound 23)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454348(US10717734, Compound 24)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454346(US10717734, Compound 22 | US10717734, Compound 23)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454346(US10717734, Compound 22 | US10717734, Compound 23)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454345(US10717734, Compound 21)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454346(US10717734, Compound 22 | US10717734, Compound 23)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454360(US10717734, Compound 36)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454361(US10717734, Compound 37)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454359(US10717734, Compound 35)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454360(US10717734, Compound 36)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454358(US10717734, Compound 34)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454359(US10717734, Compound 35)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454357(US10717734, Compound 33)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454358(US10717734, Compound 34)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454356(US10717734, Compound 32)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454357(US10717734, Compound 33)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454355(US10717734, Compound 31)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454356(US10717734, Compound 32)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454354(US10717734, Compound 30)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454355(US10717734, Compound 31)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454353(US10717734, Compound 29)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454354(US10717734, Compound 30)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454366(US10717734, Compound 42)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454365(US10717734, Compound 41)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454366(US10717734, Compound 42)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454364(US10717734, Compound 40)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454365(US10717734, Compound 41)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454363(US10717734, Compound 39)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454364(US10717734, Compound 40)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454362(US10717734, Compound 38)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454363(US10717734, Compound 39)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454361(US10717734, Compound 37)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454362(US10717734, Compound 38)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454328(US10717734, Compound 4)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454329(US10717734, Compound 5)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454327(US10717734, Compound 3)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454328(US10717734, Compound 4)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454326(US10717734, Compound 2)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM454327(US10717734, Compound 3)
Affinity DataIC50: 3.00E+3nMAssay Description:SSAO/VAP-1: Human recombinant SSAO/VAP-1 amine oxidase activity was determined using the coupled colorimetric method as described for monoamine oxida...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Pharmaxis

US Patent
LigandPNGBDBM454325(US10717734, Compound 1)
Affinity DataIC50: 3.00E+3nMAssay Description:MAO-B: The specificity of the compounds of this invention was tested by determining their ability to inhibit MAO-B activities in vitro. Recombinant h...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

Displayed 1 to 50 (of 176 total ) | Next | Last >>
Jump to: